NCH is among a select group of Illinois hospitals with DaTscanTM, the first FDA-approved radiopharmaceutical imaging agent that assists doctors in differentiating neurological conditions from parkinsonian syndromes like Parkinson's disease.
Recognizing a patient's ability to make his or her own health care decision (Decisional Capacity) is an important assessment for physicians to make, especially when a patient's consent for care is required.
CareLink Phase IV go-live has been postponed, but physicians are still encouraged to participate in the brief computer-based training (CBT) module. Read more about the upcoming enhancements and changes, and access the CBT directly from SCAN. A new go-live date is soon to be announced.
About one year after adopting Computerized Provider Order Entry (CPOE), NCH is planning to move all orders to the CareLink system where they will reside electronically, with only a few exceptions. This is tentatively scheduled for February 29.